HomeALDX • NASDAQ
add
Aldeyra Therapeutics Inc
Previous close
$4.13
Year range
$1.14 - $7.01
Market cap
248.25M USD
Avg Volume
1.05M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.67M | -59.78% |
Net income | -6.46M | 59.13% |
Net profit margin | — | — |
Earnings per share | -0.10 | 62.96% |
EBITDA | -6.60M | 60.02% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 70.04M | -30.76% |
Total assets | 72.06M | -31.11% |
Total liabilities | 27.81M | -17.24% |
Total equity | 44.25M | — |
Shares outstanding | 60.18M | — |
Price to book | 5.57 | — |
Return on assets | -22.25% | — |
Return on capital | -26.76% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -6.46M | 59.13% |
Cash from operations | -5.30M | 55.97% |
Cash from investing | 16.00M | 1,123.10% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | 10.70M | 178.72% |
Free cash flow | -3.62M | -110.84% |
About
Founded
2004
Headquarters
Website
Employees
8
